Zobrazeno 1 - 10
of 579
pro vyhledávání: '"FEI LIU"'
Publikováno v:
Journal of Oncology. 2023:1-14
Background. Cancer-associated fibroblasts (CAFs) have reported widely involved in cancer progression. However, its underlying mechanism in gastric cancer is still not clarified. Methods. The data used in this study were all downloaded from the Cancer
Autor:
Ronald Chow, Julie Midroni, Jagdeep Kaur, Gabriel Boldt, Geoffrey Liu, Lawson Eng, Fei-Fei Liu, Benjamin Haibe-Kains, Michael Lock, Srinivas Raman
Publikováno v:
JNCI: Journal of the National Cancer Institute. 115:365-374
Background The aim of this study is to provide a comprehensive understanding of the current landscape of artificial intelligence (AI) for cancer clinical trial enrollment and its predictive accuracy in identifying eligible patients for inclusion in s
Autor:
Fen-Fen, Jin, Chan-Juan, Wang, Lei, Cui, Fei-Fei, Liu, Kai-Ling, Wang, Wei-Jing, Li, Zhi-Gang, Li
Publikováno v:
Journal of Pediatric Hematology/Oncology. 45:e339-e344
Low expression levels of E2F3a and caspase 8-associated protein 2 (CASP8AP2) are associated with poor outcomes in children with acute lymphoblastic leukemia. Our previous study showed that a combined assessment of E2F3a and CASP8AP2 expression was mo
Autor:
Fei Liu, Xinyue Zhang, Ziyu Liu, Weiye Cai, Chao Song, Yan Jiang, Ji Yin, Zongchao Liu, Chenyi Huang
Publikováno v:
Journal of Oncology. 2022:1-25
Objective. Emerging evidence highlights the clinical implications of N6-methyladenosine (m6A) modification in HCC. Yet, the roles of m6A modification in modulating cancer immunity and shaping tumor microenvironment (TME) are undefined in hepatocellul
Autor:
Lingmiao Kong, Ying Xiong, Denian Wang, Luping Huang, Min Li, Zhongxue Feng, Yue Zhou, Haili Zhang, Fei Liu, Fei Xiao, Yong’gang Wei, Wei Zhang
Publikováno v:
Breast Cancer Research and Treatment. 195:91-103
Breast cancer is the most frequently diagnosed cancer and is the leading cause of cancer-associated mortality in women worldwide. Intermedin (IMD, also known as Adrenomedullin 2, ADM2) is an endogenous peptide that belongs to the calcitonin gene-rela
Autor:
Wensong Wei, Suosu Wei, Zhen Huang, Qiuhuan Zhang, Fei Liu, Yujie Xie, Jing Wei, Chongde Mo, Ying Zhou, Shengpeng Qin, Quanqing Zou, Jianrong Yang
Publikováno v:
Frontiers in Oncology. 13
BackgroundSeveral studies have analyzed the relationship between body mass index (BMI) and the prognosis of breast cancer (BC). However, whether their relationship is linear or curvilinear remains unclear. This cohort study examined the specific rela
Autor:
Chunhui Zhou, Yan Li, Jiaping Li, Botian Song, Hanfeng Li, Bin Liang, Shanzhi Gu, Haiping Li, Changyong Chen, Sai Li, Changli Peng, Fei Liu, Juxiong Xiao, Xueying Long, Ping Li, Zhengping Xiong, Xiaoping Yi, Weihua Liao, Liangrong Shi
Publikováno v:
Clinical Cancer Research.
Purpose: To assess the safety and efficacy of local ablation plus PD-1 inhibitor toripalimab in previously treated unresectable hepatocellular carcinoma (HCC). Patients and Methods: In the multicenter, two-stage, and randomized phase 1/2 trial, patie
Autor:
Yu Song, Dong Guo, Jia-Fei Liu, Li-Na Ge, Peng Liu, Ye-Min Qu, Hai-Yan Cong, Tian Li, Xin Chang, Yi-Ran Wang, Li-Ying Shao, Zong-Jun Du, Ming-Yi Wang
Publikováno v:
International Journal of Oncology. 63
Publikováno v:
Clinical and Translational Oncology.
Publikováno v:
Frontiers in Oncology. 13
ObjectiveThe aim of the study was to evaluate the similarities and differences between gallbladder adenosquamous carcinoma (GBASC) and pure gallbladder adenocarcinoma (GBAC).MethodsPatients with GBASC and GBAC from 2010 to 2020 were analyzed in terms